U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C22H23N3O6S
Molecular Weight 457.5
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ETAVOPIVAT

SMILES

OC[C@@H](C(=O)N1CC2=C(C1)CN(C2)S(=O)(=O)C3=CN=C4OCCOC4=C3)C5=CC=CC=C5

InChI

InChIKey=KZFFYEPYCVDOGE-LJQANCHMSA-N
InChI=1S/C22H23N3O6S/c26-14-19(15-4-2-1-3-5-15)22(27)24-10-16-12-25(13-17(16)11-24)32(28,29)18-8-20-21(23-9-18)31-7-6-30-20/h1-5,8-9,19,26H,6-7,10-14H2/t19-/m1/s1

HIDE SMILES / InChI
Molecular Formula C22H23N3O6S
Molecular Weight 457.5
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Unknown
149124
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
786 ng/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/35019238/
400 mg single, oral
dose: 400 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
ETAVOPIVAT plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
2652 ng/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/35019238/
700 mg single, oral
dose: 700 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
ETAVOPIVAT plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
2663 ng/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/35019238/
1000 mg single, oral
dose: 1000 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
ETAVOPIVAT plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
2847 ng × h/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/35019238/
400 mg single, oral
dose: 400 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
ETAVOPIVAT plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
7254 ng × h/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/35019238/
700 mg single, oral
dose: 700 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
ETAVOPIVAT plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
9618 ng × h/mL
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/35019238/
1000 mg single, oral
dose: 1000 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
ETAVOPIVAT plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
12.9 h
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/35019238/
400 mg single, oral
dose: 400 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
ETAVOPIVAT plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
13.8 h
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/35019238/
700 mg single, oral
dose: 700 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
ETAVOPIVAT plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
10.6 h
EXPERIMENT
https://pubmed.ncbi.nlm.nih.gov/35019238/
1000 mg single, oral
dose: 1000 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
ETAVOPIVAT plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
Substance Class Chemical
Created
by admin
on Wed Apr 02 04:52:23 GMT 2025
Edited
by admin
on Wed Apr 02 04:52:23 GMT 2025
Record UNII
V4E0A9M44Q
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ETAVOPIVAT
USAN   INN  
Official Name English
(S)-1-(5-((2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-7-yl)sulfonyl)-3,4,5,6-tetrahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)-3-hydroxy-2-phenylpropan-1-one
Preferred Name English
ETAVOPIVAT [USAN]
Common Name English
etavopivat [INN]
Common Name English
FT-4202
Code English
Etavopivat [WHO-DD]
Common Name English
1-Propanone, 1-[5-[(2,3-dihydro-1,4-dioxino[2,3-b]pyridin-7-yl)sulfonyl]-3,4,5,6-tetrahydropyrrolo[3,4-c]pyrrol-2(1H)-yl]-3-hydroxy-2-phenyl-, (2S)-
Systematic Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 728919
Created by admin on Wed Apr 02 04:52:23 GMT 2025 , Edited by admin on Wed Apr 02 04:52:23 GMT 2025
Code System Code Type Description
PUBCHEM
135338378
Created by admin on Wed Apr 02 04:52:23 GMT 2025 , Edited by admin on Wed Apr 02 04:52:23 GMT 2025
PRIMARY
INN
11646
Created by admin on Wed Apr 02 04:52:23 GMT 2025 , Edited by admin on Wed Apr 02 04:52:23 GMT 2025
PRIMARY INN
SMS_ID
300000016921
Created by admin on Wed Apr 02 04:52:23 GMT 2025 , Edited by admin on Wed Apr 02 04:52:23 GMT 2025
PRIMARY
FDA UNII
V4E0A9M44Q
Created by admin on Wed Apr 02 04:52:23 GMT 2025 , Edited by admin on Wed Apr 02 04:52:23 GMT 2025
PRIMARY
NCI_THESAURUS
C176893
Created by admin on Wed Apr 02 04:52:23 GMT 2025 , Edited by admin on Wed Apr 02 04:52:23 GMT 2025
PRIMARY
CAS
2245053-57-8
Created by admin on Wed Apr 02 04:52:23 GMT 2025 , Edited by admin on Wed Apr 02 04:52:23 GMT 2025
PRIMARY
USAN
KL-51
Created by admin on Wed Apr 02 04:52:23 GMT 2025 , Edited by admin on Wed Apr 02 04:52:23 GMT 2025
PRIMARY
Related Record Type Details
PYRUVATE KINASE PKR
TARGET -> ACTIVATOR
activator to 89% of activity
EC50
Related Record Type Details
Structure of ETAVOPIVAT
ACTIVE MOIETY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966